Geron (GERN) releases positive data from a clinical trial of its human embryonic stem cell-based...

|About: Geron Corporation (GERN)|By:, SA News Editor

Geron (GERN) releases positive data from a clinical trial of its human embryonic stem cell-based therapy. JPMorgan initiates coverage with an Overweight rating. Shares +5.4% premarket.